Dexcom (DXCM) Return on Capital Employed (2011 - 2026)
Dexcom (DXCM) posted quarterly Return on Capital Employed of 27.21% for Q2 2026, up 879.0% year-over-year from 2.78% in Q2 2025, and up 12.23% quarter-over-quarter from 24.24% in Q1 2026.
Dexcom (DXCM) Return on Capital Employed (2011 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Return on Capital Employed for 16 consecutive years, with 27.21% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Capital Employed rose 879.0% year-over-year to 27.21%; the TTM figure through Jun 2026 stood at 27.21% (up 879.0% YoY), while the FY2025 annual figure was 21.36%, up 393.0% from the prior year.
- Return on Capital Employed improved to 27.21% in Q2 2026 per DXCM's latest filing, from 24.24% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 27.21% in Q2 2026 and bottomed at 5.48% in Q2 2022.
- Historically, Return on Capital Employed has averaged 14.31% across 5 years, with a median of 13.3% in 2024.
- Annual changes were most pronounced in 2022 — Return on Capital Employed sank 349 bps — and 2026, when it surged 879 bps.
- Dexcom's Return on Capital Employed stood at 11.83% in 2022, then climbed by 4 bps to 12.26% in 2023, then jumped by 40 bps to 17.21% in 2024, then climbed by 11 bps to 19.09% in 2025, then soared by 43 bps to 27.21% in 2026.
- Business Quant data shows DXCM's Return on Capital Employed at 27.21% in Q2 2026, 24.24% in Q1 2026, and 19.09% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 6.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.21% |
| Mar 31, 2026 | 24.24% |
| Dec 31, 2025 | 19.09% |
| Sep 30, 2025 | 19.07% |
| Jun 30, 2025 | 18.42% |
| Mar 31, 2025 | 17.67% |
| Dec 31, 2024 | 17.21% |
| Sep 30, 2024 | 12.97% |
| Jun 30, 2024 | 13.86% |
| Mar 31, 2024 | 13.63% |
| Dec 31, 2023 | 12.26% |
| Sep 30, 2023 | 10.06% |
| Jun 30, 2023 | 10.94% |
| Mar 31, 2023 | 11.06% |
| Dec 31, 2022 | 11.83% |
| Sep 30, 2022 | 6.41% |
| Jun 30, 2022 | 5.48% |
| Mar 31, 2022 | 6.10% |
| Dec 31, 2021 | 6.43% |
| Sep 30, 2021 | 9.45% |